Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 7/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9839122 | 0.86 | L3MBTL1 (0.44) | SMN1; SMN2L3MBTL1LTA4H | |
| SCHEMBL883999 | 0.83 | SMN1; SMN2 (0.44) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL13740434 | 0.81 | SMN1; SMN2 (0.57) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL1463818 | 0.81 | S1PR5 (0.43) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL13739335 | 0.81 | SMN1; SMN2 (0.57) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL934458 | 0.81 | SMN1; SMN2 (0.57) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL1361559 | 0.81 | S1PR5 (0.43) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL2707889 | 0.81 | S1PR5 (0.43) | CYP1A2S1PR5S1PR4S1PR1S1PR3 | |
| SCHEMBL1361486 | 0.80 | S1PR4 (0.43) | S1PR5S1PR4S1PR1S1PR3 | |
| Hydrochloric Acid SCHEMBL22465761 | 0.79 | SMN1; SMN2 (0.44) | CYP1A2S1PR5S1PR4S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010049678-A2 | TREATMENT OF ENERGY UTILIZATION DISEASES | SUMMIT CORPORATION PLC (GB) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010029313-A1 | ANTIINFECTIVE COMPOUNDS | SUMMIT CORPORATION PLC. (GB) | 2010-03-18 | — | — | WO | disclosed |
| WO-2010015815-A2 | COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS | SUMMIT CORPORATION PLC (GB) | 2010-02-11 | — | — | WO | disclosed |